Initial steroid-free immunosuppression after liver transplantation in recipients with hepatitis c virus related cirrhosis

Figure 1 A: Actual patient survival according to primary indi-cation (HCV related cirrhosis vs others) of liver recipients re-ceiving steroid-free immunosuppression. B: Actual rejection free interval according to primary indication (HCV related cir-rhosis vs others) during the first year after LTx in liver recipi-ents receiving steroid- free initial immunosuppression.

Figure 2 Serum virus concentration in seven HCV infected recipients during the first year after LTx. All patients received initial steroid-free immunosuppression.